Skip to main content
. 2021 Jul 15;13(14):3547. doi: 10.3390/cancers13143547

Figure 3.

Figure 3

Kaplan–Meier estimations of the 6-month and 1-year probabilities of duration of response after cemiplimab treatment for the per-protocol population (n = 240).